©2023 Cognivue, Inc. | Privacy Policy | References
Cognivue Names Renowned Neuroscientist Dr. James E. Galvin as Chief Scientific Officer
ROCHESTER, NY (March 7, 2023) Renowned neuroscientist Dr. James E. Galvin has joined Cognivue as Chief Scientific Officer. He is the founding director of the Comprehensive Center for Brain Health, professor of…
Cognivue National Study Draws Remarkable 37 Percent Participation Rate of Historically Underrepresented Populations
ROCHESTER, NY (February 7, 2023) Neuroscience company Cognivue has a reported a remarkable 37 percent research participation rate of historically underserved and underrepresented populations in its national Further the Objective and Clinical…
BEYOND THE AUDIOGRAM: Whole-Brain Hearing and Listening
BEYOND THE AUDIOGRAM: Whole-Brain Hearing and Listening Difficulty hearing in noise often drives older adults to seek help, but most hearing screening tests for loudness, not clarity. Both measures are needed for…
Still Battling Turf Wars: 2022
Tech Topic | November 2022 Hearing Review Turf wars are sometimes disguised as SOP issues By Douglas L. Beck, AuD Article link After 10 years of working primarily in the operating room, I…
Cognivue Launches National Study to Further Differentiate Patented Cognitive Assessment Systems
ROCHESTER, NY (July 26, 2022) Neuroscience company Cognivue will launch a large-scale U.S. study next month to further differentiate the effectiveness of its cognitive assessment systems. The Further, Objective, Clinical, Understanding, Study…
Cognivue Recruits National Leaders for Audiology Advisory Committee
ROCHESTER, NY (June 28, 2022) Neuroscience company Cognivue has recruited 16 national leaders for its new Audiology Advisory Committee. Cognivue is an emerging leader in cognitive assessment technologies, data collection, and training…
Cognivue Appoints Douglas L. Beck, Au.D., as Vice President of Clinical Sciences
Beck Brings Four Decades of Experience in Audiology and Communication Disorders and Sciences to Cognivue ROCHESTER, NY (April 12, 2022)—Neuroscience company Cognivue, Inc. has hired Dr. Douglas L. Beck as Vice President…
Avan Institute In Partnership With Cognivue Awarded Grant to Launch Innovative Early Detection Program For Alzheimer’s In Pharmacies Nationwide
Avant Institute is One of Twelve Select Recipients of the Inaugural Global Davos Alzheimer’s Collaborative Grant Program for Healthcare System Preparedness CHARLOTTE, NC (JUNE 8, 2022) – Avant Institute, in partnership with…
Cognivue Recruits Top Scientists for Clinical Advisory Board
ROCHESTER, NY, March 22, 2022 – Neuroscience company Cognivue, Inc. has recruited eight highly respected professionals in the fields of neuroscience, geriatric medicine, psychiatry, and medicine for its new clinical advisory board….
Cognivue & DigiCARE Realized Partner to Offer Health Systems an AI-Powered Approach
ROCHESTER, N.Y. (Aug. 2, 2023)—Cognivue, Inc. and DigiCARE Realized today announced a strategic partnership to improve routine brain care across health care systems, focusing on earlier detection of Alzheimer’s disease and related dementias (ADRD).
Coming on the heels of the landmark FDA approval of Leqembi, this collaboration will draw upon two transformative cognitive assessment technologies. DigiCARE Realized’s artificial...
Cognivue Names Renowned Neuroscientist Dr. James E. Galvin as Chief Scientific Officer
ROCHESTER, NY (March 7, 2023) Renowned neuroscientist Dr. James E. Galvin has joined Cognivue as Chief Scientific Officer. He is the founding director of the Comprehensive Center for Brain Health, professor of…
Cognivue National Study Draws Remarkable 37 Percent Participation Rate of Historically Underrepresented Populations
ROCHESTER, NY (February 7, 2023) Neuroscience company Cognivue has a reported a remarkable 37 percent research participation rate of historically underserved and underrepresented populations in its national Further the Objective and Clinical…
BEYOND THE AUDIOGRAM: Whole-Brain Hearing and Listening
BEYOND THE AUDIOGRAM: Whole-Brain Hearing and Listening Difficulty hearing in noise often drives older adults to seek help, but most hearing screening tests for loudness, not clarity. Both measures are needed for…
Still Battling Turf Wars: 2022
Tech Topic | November 2022 Hearing Review Turf wars are sometimes disguised as SOP issues By Douglas L. Beck, AuD Article link After 10 years of working primarily in the operating room, I…
Cognivue Launches National Study to Further Differentiate Patented Cognitive Assessment Systems
ROCHESTER, NY (July 26, 2022) Neuroscience company Cognivue will launch a large-scale U.S. study next month to further differentiate the effectiveness of its cognitive assessment systems. The Further, Objective, Clinical, Understanding, Study…
Cognivue Recruits National Leaders for Audiology Advisory Committee
ROCHESTER, NY (June 28, 2022) Neuroscience company Cognivue has recruited 16 national leaders for its new Audiology Advisory Committee. Cognivue is an emerging leader in cognitive assessment technologies, data collection, and training…
Cognivue Appoints Douglas L. Beck, Au.D., as Vice President of Clinical Sciences
Beck Brings Four Decades of Experience in Audiology and Communication Disorders and Sciences to Cognivue ROCHESTER, NY (April 12, 2022)—Neuroscience company Cognivue, Inc. has hired Dr. Douglas L. Beck as Vice President…
Avan Institute In Partnership With Cognivue Awarded Grant to Launch Innovative Early Detection Program For Alzheimer’s In Pharmacies Nationwide
Avant Institute is One of Twelve Select Recipients of the Inaugural Global Davos Alzheimer’s Collaborative Grant Program for Healthcare System Preparedness CHARLOTTE, NC (JUNE 8, 2022) – Avant Institute, in partnership with…
Cognivue Recruits Top Scientists for Clinical Advisory Board
ROCHESTER, NY, March 22, 2022 – Neuroscience company Cognivue, Inc. has recruited eight highly respected professionals in the fields of neuroscience, geriatric medicine, psychiatry, and medicine for its new clinical advisory board….